CH396314A - Verfahren zur Herstellung von Toxoiden aus bakteriellen Toxinen - Google Patents
Verfahren zur Herstellung von Toxoiden aus bakteriellen ToxinenInfo
- Publication number
- CH396314A CH396314A CH7429259A CH7429259A CH396314A CH 396314 A CH396314 A CH 396314A CH 7429259 A CH7429259 A CH 7429259A CH 7429259 A CH7429259 A CH 7429259A CH 396314 A CH396314 A CH 396314A
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- toxin
- days
- mixture
- stand
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 13
- 231100000699 Bacterial toxin Toxicity 0.000 title claims description 11
- 239000000688 bacterial toxin Substances 0.000 title claims description 11
- WNFHGZLVUQBPMA-JSCKKFHOSA-M Sodium glucuronate Chemical compound [Na+].O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C([O-])=O WNFHGZLVUQBPMA-JSCKKFHOSA-M 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- 102000016607 Diphtheria Toxin Human genes 0.000 claims description 13
- 108010053187 Diphtheria Toxin Proteins 0.000 claims description 13
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 13
- 229940097043 glucuronic acid Drugs 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 claims description 6
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 claims description 6
- 229950002441 glucurolactone Drugs 0.000 claims description 6
- 108010055044 Tetanus Toxin Proteins 0.000 claims description 5
- 229940118376 tetanus toxin Drugs 0.000 claims description 5
- 201000005702 Pertussis Diseases 0.000 claims description 4
- 241000191940 Staphylococcus Species 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 claims 1
- 108700012359 toxins Proteins 0.000 description 21
- 239000003053 toxin Substances 0.000 description 20
- 231100000765 toxin Toxicity 0.000 description 20
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 14
- 231100000252 nontoxic Toxicity 0.000 description 12
- 230000003000 nontoxic effect Effects 0.000 description 12
- 230000001147 anti-toxic effect Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000011550 stock solution Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000000872 buffer Substances 0.000 description 9
- 229910021538 borax Inorganic materials 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 239000004328 sodium tetraborate Substances 0.000 description 6
- 235000010339 sodium tetraborate Nutrition 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101100294184 Mus musculus Ninl gene Proteins 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1648658 | 1958-06-12 | ||
| JP1728859 | 1959-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH396314A true CH396314A (de) | 1965-07-31 |
Family
ID=26352832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH7429259A CH396314A (de) | 1958-06-12 | 1959-06-11 | Verfahren zur Herstellung von Toxoiden aus bakteriellen Toxinen |
Country Status (3)
| Country | Link |
|---|---|
| CH (1) | CH396314A (en)) |
| FR (1) | FR447M (en)) |
| GB (1) | GB919782A (en)) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3621005A (en) * | 1967-08-21 | 1971-11-16 | Zaidan Hojin Tokyo Seikagaku | Ppd-s (tuberculin protein) combined with glucuronic acid and method for preparing the same |
-
1959
- 1959-06-11 GB GB20017/59A patent/GB919782A/en not_active Expired
- 1959-06-11 CH CH7429259A patent/CH396314A/de unknown
-
1960
- 1960-08-30 FR FR837140A patent/FR447M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR447M (en)) | 1961-04-24 |
| GB919782A (en) | 1963-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2036114C3 (de) | Wäßriges Tetramisolpräparat | |
| DE2219635B2 (de) | Insulinsalz-Protamin-Komplexe und Verfahren zu ihrer Herstellung | |
| CH396314A (de) | Verfahren zur Herstellung von Toxoiden aus bakteriellen Toxinen | |
| DE861904C (de) | Verfahren zur Herstellung von loeslichen Riboflavinpraeparaten | |
| DE2704708A1 (de) | Stabile injizierbare zubereitungen und verfahren zu ihrer herstellung | |
| DE1617344A1 (de) | Verfahren zur Herstellung einer Tetanus-Vaccine | |
| DE657129C (de) | Verfahren zur Herstellung von Loesungen oder Extrakten aus Bakterien, Pollen oder sonstigen pflanzlichen Zellen | |
| DE738908C (de) | Herstellung von Eiweissstoffen | |
| AT234275B (de) | Verfahren zur Herstellung von Vaccinen aus Toxoiden bzw. Toxinen von Clostridium perfringens | |
| DE629841C (de) | Verfahren zur Herstellung einer waessrigen Chininloesung fuer Injektionszwecke | |
| DE2309263C2 (de) | Infusionskonzentrat mit Gehalt an 5,5-Diphenylhydantoin-Natrium | |
| DE642980C (de) | Verfahren zur Herstellung von therapeutisch wirksamen Loesungen aus Bakterien | |
| DE922310C (de) | Verfahren zur Herstellung waessriger, zur Schaedlingsbekaempfung geeigneter Dispersionen | |
| DE2036113A1 (de) | Tetramisolpraparate | |
| AT231614B (de) | Verfahren zur Herstellung von künstlichen Mineralwässern bzw. künstlich verstärkten Mineralwässern | |
| DE1226744B (de) | Naehrmedien fuer lebendes Gewebe | |
| DE419658C (de) | Verfahren zur Herstellung eines wasserloeslichen Eindampfproduktes aus Latex | |
| DE535676C (de) | Verfahren zur Herstellung von Bekaempfungsmitteln gegen bakterielle Krankheiten | |
| DE949912C (de) | Verhinderung und Vertilgung von Unkraut | |
| DE884856C (de) | Verfahren zur Herstellung von den anti-perniciosa-anaemischen Faktor enthaltenden Zubereitungen | |
| AT114598B (de) | Verfahren zur Herstellung von antiseptisch wirkenden Mitteln. | |
| DE963365C (de) | Verfahren zur Herstellung von Blutersatzmitteln | |
| DE814317C (de) | Verfahren zur Herstellung haltbarer Loesungen von Penicillin liefernden Praeparaten | |
| DE936232C (de) | Verfahren zur Herstellung bestaendiger injizierbarer Loesungen von 4-Dimethylamino-1-phenyl-2, 3-dimethylpyrazolon | |
| AT216137B (de) | Verfahren zur Herstellung eines therapeutischen Präparates |